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https://doi.org/10.1016/j.stemcr.2017.12.023SUMMARYInmouse, although four Argonaute (AGO) proteins with partly overlapping functions in small-RNA pathways exist, onlyAgo2 deficiency
causes embryonic lethality. To investigate the role of AGO2 duringmouse early development, we generatedAgo2-deficientmouse embry-
onic stem cells (mESCs) and performed a detailed characterization of their differentiation potential. Ago2 disruption caused a global
reduction of microRNAs, which resulted in the misregulation of only a limited number of transcripts. We demonstrated, both in vivo
and in vitro, that AGO2 is dispensable for the embryonic germ-layer formation. However, Ago2-deficient mESCs showed a specific defect
during conversion into extra-embryonic endoderm cells. We proved that this defect is cell autonomous and can be rescued by both a
catalytically active and an inactive Ago2, but not by Ago2 deprived of its RNA binding capacity or by Ago1 overexpression. Overall,
our results suggest a role for AGO2 in stem cell differentiation.INTRODUCTION
RNA-silencing pathways play an important role in a wide
range of biological processes, including regulation of
animal development, cell proliferation, and differentiation
(Ghildiyal and Zamore, 2009). In mammals, microRNAs
(miRNAs) are the main RNA-silencing molecules and are
involved in the post-transcriptional regulation of gene
expression (Jonas and Izaurralde, 2015). miRNAs are about
22 nt long RNA molecules processed from longer hairpin
transcripts by the consecutive cleavage of the RNase III-like
enzymes DROSHA and DICER (Ha and Kim, 2014). Mature
miRNAs are subsequently loaded into an Argonaute (AGO)
protein to form the RNA-induced silencing complex, which
leads to the destabilization or translational repressionof the
target transcripts. Out of the four AGO proteins (AGO1–4)
that share structural similarities (Meister, 2013) and have
overlapping functions in the miRNA pathway (Su et al.,
2009;Wang et al., 2012a), only AGO2possesses an endonu-
clease catalytic activity (Liu, 2004). In mice, the deletion of
the Ago2 gene leads to embryonic lethality, while Ago1,
Ago3, and Ago4 deletions are viable (Alisch et al., 2007;
Cheloufi et al., 2010; Liu, 2004; Modzelewski et al., 2012;
Morita et al., 2007; O’Carroll et al., 2007; Van Stry et al.,
2012). The developmental arrest observed in Ago2 mutant
embryos occurs post-implantation and is not dependent
on its catalytic activity (Cheloufi et al., 2010).
At implantation, themouse embryo is composed of three
lineages: the trophectoderm that will give rise to theStem Cell Rep
This is an open access article under the Cplacenta, the primitive endoderm (PrE) contributing to
the yolk sac, and the epiblast (EPI), which will form the
embryo proper (Arnold and Robertson, 2009; Rossant and
Tam, 2009). The EPI and PrE are specified within the
inner cell mass (ICM) at the blastocyst stage. This process
is characterized by the mutually exclusive expression of
lineage-specific transcription factors: NANOG in the EPI-
biased cells versus GATA6 in the PrE-biased cells (Chazaud
and Yamanaka, 2016). The fibroblast growth factor
4/mitogen-activated protein kinase (FGF4/MAPK)
signaling pathway governs this cell-fate choice by promot-
ing the expression of PrE genes and the repression of EPI
genes within the initially homogeneous ICM (Chazaud
et al., 2006; Kang et al., 2012; Nichols et al., 2009; Yama-
naka et al., 2010). In this process, Gata6 is downstream of
the FGF-signaling pathway and upstream of secondary
extra-embryonic endoderm (ExEn) genes such as Gata4,
Pdgfra, and Sox17 (Artus et al., 2010, 2011; Chazaud et al.,
2006; Niakan et al., 2010; Plusa et al., 2008). Gata6mutant
embryos die post-implantation and display a compromised
PrE differentiation (Bessonnard et al., 2014; Koutsourakis
et al., 1999; Morrisey et al., 1998; Schrode et al., 2014).
In vitro, Gata6 mutant mouse embryonic stem cells
(mESCs) cannot induce the expression of ExEn genes and
fail to establish ExEn lineage during embryoid body (EB)
formation (Capo-chichi et al., 2005).
In order to investigate the roles of AGO2 in pluripotent
stem cells, we generated Ago2 knockout (Ago2_KO) mESCs
and assessed their differentiation potential in vitro andorts j Vol. 10 j 461–476 j February 13, 2018 j ª 2017 The Author(s). 461
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Characterization of Ago2 Knockout mESCs and Impact on Gene Expression
(A) Top: schematic representation of the CRISPR/Cas9-mediated Ago2_KO strategy. Bottom: representative pictures of the wild-type (WT)
and Ago2_KO mESC clones. Scale bars, 50 mm.
(B) Relative expression of Ago2 mRNA in WT, Ago2_KO1, and Ago2_KO2 mESCs, measured by RT-qPCR. The error bars show the SD of three
independent experiments.
(C) Western blot analysis of AGO2 and OCT4 protein levels in WT and Ago2_KO mESCs. TUBULIN is used as loading control.
(D) Relative expression of Oct4, Nanog, and Sox2mRNAs in WT and Ago2_KO cells, measured by RT-qPCR. The error bars show the SD of three
independent experiments.
(legend continued on next page)
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in vivo. AlthoughAgo2_KOmESCs successfully differentiate
toward the three embryonic germ layers, they were unable
to give rise to ExEn during EB differentiation and conver-
sion of mESCs to ExEn stem cells (XEN) (Cho et al., 2012;
Kunath, 2005). The deletion of Ago2 results in an impaired
expression ofGATA6 protein and ExEn genes during in vitro
XEN conversion, leading to a cell-autonomous differentia-
tion defect. The observed phenotype is specific to Ago2 and
overexpression of AGO1 in Ago2_KO mESCs does not
rescue the phenotype. Finally, we demonstrate that the
catalytic function of AGO2 is not required, whereas its
small-RNA binding capacity is essential for the XEN con-
version of Ago2_KO mESCs. Our findings provide insights
into the understanding of AGO2 function during stem
cell differentiation and identify AGO2 as a player in ExEn
formation in vitro.RESULTS
Generation of Argonaute Knockout Mutant mESCs
In order to assess the role of Ago2 in mESC differentiation,
we generated two independent mESC knockout clones
(Ago2_KO1 and Ago2_KO2) carrying different genomic
deletions generated through CRISPR/Cas9 genome editing
(Doudna and Charpentier, 2014) (Figure 1A, top). Inactiva-
tion of Ago2 was confirmed at the RNA and protein levels
(Figures 1B and 1C). Both clones did not show any obvious
morphological difference compared with the wild-type
(WT) mESC colonies (Figure 1A, bottom) and presented
no changes in expression of the core pluripotency factors
Oct4, Nanog, and Sox2 (Figures 1C and 1D).
As AGO1 is the only other AGO protein expressed in
mESCs, we generated Ago1_KO mESCs (Ago1_KO1 and
Ago1_KO2) using the same gene deletion strategy (Figures
S1A–S1C). Although the alteration of the miRNA biogen-
esis pathway may negatively affect the cell cycle (Greve
et al., 2013), we observed no significant variation in the
cell cycle for Ago2_KO and Ago1_KO compared with WT(E) Cell-cycle analysis of WT, Ago2_KO1, Ago2_KO2, Ago1_KO1, and Ago
G1 phase of the cell cycle. The values were obtained from three inde
(F) Boxplots depicting the global levels of miRNAs in WT, Ago2_KO
normalized miRNA reads are represented as the mean of two replic
significance (****p < 0.0001) was assessed using non-parametrical M
was calculated by comparing the mean miRNA levels in each conditio
(G) Scatterplot representing the miRNA levels in CPTM after AGO1 an
AGO1-loaded miRNAs in WT cells are represented in blue and green. Th
represented in red. Group 2 defines miRNAs 2-fold less enriched in Ago2
group 1. Four miRNAs from group 2, validated by northern blot (Figu
(H) Volcano plots representing the differentially expressed genes in A
RNA-seq data represent the mean expression of two independent
p value <0.01) up- and downregulated genes are highlighted in red a
See also Figure S1.mESCs (Figure 1E). Interestingly, we noticed an upregula-
tion of AGO1 at the protein level but not at themRNA level
in Ago2_KO mESCs (Figures S1B and S1C), consistent with
the notion that increased availability of miRNAs consecu-
tive to the absence of AGO2 may impact the stability of
AGO1 (Smibert et al., 2013).Ago2 Knockout mESCs Show Reduced miRNA Levels
with a Limited Impact on the Transcriptome
The generation of small-RNA libraries from WT, Dicer_KO,
Ago1_KO, and Ago2_KOmESCs revealed a global reduction
of the whole miRNA population (3.8-fold) in Ago2_KO and
no significant downregulation ofmiRNA levels inAgo1_KO
compared with WT mESCs (Figures 1F and S1D and
Table S1). As expected, the Dicer_KO cells showed a strong
reduction of miRNAs (13.4-fold) (Figure 1F). The expres-
sion of selected miRNAs was validated by northern blot
(Figure S1E, top).
To assess whether all miRNAs could be loaded into AGO1
in the absence of AGO2, we performed immunoprecipita-
tion of small RNAs charged in either AGO1 or AGO2
proteins in WT and Ago2_KO cells. While all miRNAs are
bound to both proteins inWTmESCs, we observed a stron-
ger enrichment of some miRNAs loaded in AGO1 in
Ago2_KO (defined as group 1), whereas other miRNAs
(defined as group 2) were not or were poorly loaded in
AGO1 (Figure 1G). Those group 2 miRNAs were more
affected by the loss of AGO2, incorporated less into
AGO1, and were not detectable by northern blot in
Ago2_KO mESCs (Figures 1G and S1E, bottom). Neverthe-
less, we did not detect any miRNA-specific sequence or
length signatures distinguishing the two groups.
To establish the consequences of the global miRNA
downregulation in Ago2_KOmESCs, we analyzed the tran-
scriptome of WT and Ago2_KO mESCs by RNA sequencing
(RNA-seq). Surprisingly, we identified only 22 genes
significantly upregulated in Ago2_KO compared with WT
mESCs, which could be potential direct miRNA targets1_KO2. Stacked bars represent the percentage of cells in G2/M, S, or
pendent experiments.
, Ago1_KO, and Dicer_KO mESCs measured by small-RNA-seq. The
ates (except for Dicer_KO) in counts per 10 million (CPTM). The
ann-Whitney ranked test. The fold change (FC) relative to WT cells
n.
d AGO2 immunoprecipitation compared with WT mESCs. AGO2- and
e AGO1-loaded miRNAs in Ago2_KO mESCs from groups 1 and 2 are
_KO compared with WT mESCs. The remaining miRNAs are defined as
re S1E), are highlighted.
go2_KO (left) and Dicer_KO (right) cells compared with WT mESCs.
biological replicates. Significantly (fold change >2 and adjusted
nd blue, respectively.
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Figure 2. Embryoid Body Differentiation of Ago2_KO mESCs
(A) Schematic representation of the EB differentiation protocol. LIF, leukemia inhibitory factor.
(B) Western blot showing the expression of AGO2, FOXA2, OCT4, GATA6, and NANOG proteins after 0, 2, 4, 6, and 10 days of EB differ-
entiation of WT and Ago2_KO1 mESCs. TUBULIN is shown as loading control.
(legend continued on next page)
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(Figures 1H, left, and S1F and Table S2). For comparison,
710 transcripts were significantly upregulated in Dicer_KO
mESCs (Figure 1H, right) (Bodak et al., 2017). Taken
together, our results highlight the predominant role of
AGO2 in the miRNA pathway in mESCs. Although Ago2
deletion globally destabilizes miRNAs, it does not signifi-
cantly impair the mESC gene expression patterns.
Impaired Expression of Extra-embryonic Endoderm
Markers in Ago2_KO Embryoid Bodies
To assess the role of Ago2 in mESC differentiation, we
generated EB from Ago2_KO and WT mESCs and moni-
tored the expression of different markers (Figures 2A–2C).
During EB formation, mESCs differentiate into cell types
derived from the three germ layers surrounded by an outer
layer of ExEn. For both Ago2_KO andWTcells, we observed
a similar downregulation of the pluripotency factor OCT4
(Figure 2B) and upregulation of ectoderm (Nestin, Fgf5,
Pax6) and mesoderm (Brachyury, Fgf8, Actc1) markers (Fig-
ure 2C) over time. In contrast, the expression of Gata6,
Gata4, and Foxa2, expressed in both extra-embryonic and
definitive endoderm (DE), was severely impaired in
Ago2_KO compared with WT cells (Figures 2B and 2C).
Interestingly, expression of Cxcr4, Cldn6, and Foxa1,which
are preferentially expressed in DE (Wang et al., 2012b), was
similar in Ago2_KO1 and WT differentiated cells (Fig-
ure S2A). In contrast, the expression ofDab2, a gene prefer-
entially expressed in ExEn, was strongly reduced in
Ago2_KO compared with WT cells (Figure 2C), suggesting
that ExEn but not DE differentiation was affected in
Ago2-deficient cells. To confirm this observation, we used
a direct differentiation protocol of mESCs toward DE (Fig-
ure S2B) (Gouon-Evans et al., 2006) and found that
Ago2_KO and WT cells were equally competent to give
rise to DE precursor cells expressing high levels of CXCR4
and c-KIT (Figures S2C and S2D). We subsequently per-
formed immunostaining on sections of 10 day old EBs (Fig-
ure 2D). Contrary to WT EBs, having an outer epithelial
layer of ExEn cells expressing GATA6, SOX17, GATA4,
and DAB2, the majority of the Ago2_KO EBs were lacking
an outer epithelial layer and showed a strongly reduced
expression of GATA6, SOX17, and DAB2 (Figure 2D). A var-
iable expression of GATA4 was still observed on the outer
layer in some Ago2_KO EBs. Moreover, we noticed a persis-
tent weak expression of NANOG pluripotency factor in(C) Relative gene expression of ectoderm, mesoderm, and endoderm
entiation measured by RT-qPCR. The levels at day 6 (d6) and day 10 (
Error bars represent the SD of three biological replicates. The dashed
(D) Immunofluorescence on EB sections after 10 days of EB differentia
of three different sections is shown for each of the proteins: NANOG, G
33342. Scale bar, 50 mm.
See also Figure S2.Ago2_KO EBs compared with WT, by both western blot
and immunofluorescence (Figures 2B and 2D). The defect
in ExEn differentiation was specific for the Ago2_KO
mESCs, as both normal expression of markers and differen-
tiation of an outer epithelial layer were observed for
Ago1_KO mESCs (Figures S2E and S2F). Altogether, our
data show that in the absence of Ago2, mESCs can exit
from the pluripotency state and differentiate into deriva-
tives of the three germ layers, but are defective in the
formation or the maintenance of ExEn.
Ago2-Deficient mESCs Differentiate into Embryonic
Germ Layers
To further investigate whether Ago2_KO mESCs were able
to differentiate into DE in vivo, we generated chimeric
mice with untagged and GFP-tagged WT and Ago2_KO
mESCs (Figures S3A and S3B). Chimeras were obtained
with similar efficiency following injections of mESCs of
both genotypes into C57BL/6N blastocysts (Figures 3A
and S3C–S3E). Mouse ESC contribution to internal organs
was monitored by simple sequence length polymorphism
(SSLP) genotyping PCR on mouse tissues derived from the
three embryonic germ layers: ectoderm (brain, eyes, skin),
DE (thymus, lung, liver), andmesoderm (heart, spleen, kid-
ney). We took advantage of several microsatellite repeats
that are polymorphic between injected mESCs (E14 line,
129/Ola strain) and the recipient blastocyst (C57BL/6
strain) (Figures 3A, S3C, S3D, and S3F). Similar variable
contribution to internal organs was observed for both WT
and Ago2_KO mESCs. We also monitored the contribution
of WT-GFP and Ago2_KO-GFP mESCs to the adult pancreas
by fluorescence microscopy (Figure 3B). We observed a
clear co-localization of GFP with insulin in beta-islet cells
and with pancreatic amylase in acinar/duct cells. In addi-
tion, we performed fluorescence-activated cell sorting anal-
ysis of dissociated pancreatic cells using the FOXA2 DE
marker (Figure 3C). A similar proportion of GFP-positive
cells among FOXA2-positive pancreatic cells was observed
in both WT and Ago2_KO chimeras, indicating that
Ago2_KO-GFP mESCs contributed normally to the forma-
tion of DE-derived adult pancreatic lineages. Since
FOXA2 marker showed no co-staining with immune cell
markers (CD45+ and CD11b) (Figure S3G), we can exclude
a contribution from infiltrating immune cells of meso-
dermal origin to the FOXA2 and GFP double-positivemarkers in WT, Ago2_KO1, and Ago2_KO2 mESCs during EB differ-
d10) are represented relative to the levels in WT cells at day 0 (d0).
line shows levels at d0.
tion of WT, Ago2_KO1, and Ago2_KO2 cells. The fluorescence signal
ATA6, SOX17, GATA4, and DAB2. The nuclei are stained with Hoechst
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Figure 3. Generation and Analysis of Chimeric Mice
(A) SSLP PCR genotyping on DNA from tissues derived from WT and Ago2_KO chimeras. The contribution of the cells to the tissues was
assessed following D19mit19 and D18mit184 microsatellite length. mESCs (129/Ola strain) were injected into recipient blastocysts
(C57BL/6 strain). DNA from 129/Ola and C57BL/6 mouse strains was used as control. The pictures of the tested chimeras with various
degrees of coat chimerism are presented on the left side.
(B) Immunofluorescence analysis of sections of pancreas extracted from adult Ago2_KO-GFP and WT-GFP chimeras. Sections from WT
C57BL/6N are used as GFP-negative controls. As previously, WT and Ago2_KO2 mESCs expressing GFP were injected into recipient C57BL/6
blastocysts. Representative epifluorescence pictures show GFP-expressing cells, insulin-expressing pancreatic beta islets, and amylase-
expressing acinar cells in non-fixed sections. Some co-expressing cells are indicated with a white arrow. Nuclei are stained with DAPI.
(C) Flow-cytometry analysis of GFP and FOXA2 definitive endoderm marker expression in pancreatic cells derived from WT-GFP and
Ago2_KO-GFP chimeras. Pancreatic cells from WT C57BL/6 mice are used as unstained control.
See also Figure S3.
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(legend on next page)
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pancreatic cell population. Taken together our data show
that Ago2 is dispensable for the formation of the three em-
bryonic germ layers including the DE.
AGO2 Is Required for ExEn Stem Cell Conversion
To better characterize the defect of Ago2_KO mESC differ-
entiation into ExEn in vitro, we treated WT, Ago1_KO, and
Ago2_KOmESCswith lowdoses of retinoic acid andActivin
A in order to promote their differentiation into cXEN cells
(Cho et al., 2012; Niakan et al., 2013) (Figure 4A). After
5 days of differentiation, we observed the formation of
cXEN colonies exhibiting the characteristic epithelial-like
morphology for both WT and Ago1_KO cells. In contrast,
the two Ago2_KO lines predominantly showed an atypical
fibroblast-like morphology (Figure 4A). The induction of
secondary ExEnmarkers was strongly impaired inAgo2_KO
compared with WTand Ago1_KO cXENs, while the expres-
sion of Gata6 mRNA was only slightly diminished (Fig-
ure 4B). Interestingly, NANOG and OCT4 proteins were
not detectable after 5 days of XEN conversion in all geno-
types, whereas GATA6 protein expression was strongly
reduced only in Ago2_KO cXENs (Figure 4C). To verify
whether these observations were related to a differentia-
tion delay, we performed a cXEN conversion time-course
experiment over 8–9 days.We recapitulated previous obser-
vations (Figures 4D and 4E) and observed that Ago2 expres-
sion was maintained all over the time course in WT cells
(Figure S4A). Although GATA6 levels have been shown to
be stabilized by the BMI1 in XEN cells (Lavial et al.,
2012), we observed no variation of this protein in Ago2_KO
compared with WT cXENs (Figure S4B). We next assessed
the chromatin status at the promoter of Gata6 and otherFigure 4. cXEN Conversion of WT, Ago2_KO, and Ago1_KO Cells
(A) Schematic representation of the cXEN conversion protocol. Rep
Ago1_KO2 cells after 5 days of cXEN differentiation. cXEN colonies ar
(B) Relative gene expression of ExEn markers in WT, Ago1_KO, and Ago
RT-qPCR. The error bars represent the SD of three biological replicates
Dunnett’s multiple comparison for the set of ExEn markers in Ago1_KO
conversion. The calculated p values are WT versus Ago1_KO1 (p = 0.16
(**p = 0.0061), and WT versus Ago2_KO2 (*p = 0.0417).
(C) Expression of the AGO1, AGO2, GATA6, NANOG, and OCT4 protein
Ago2_KO1 cells by western blot. TUBULIN is shown as loading contro
(D) Western blot analysis of GATA6 and NANOG levels at several time p
staining (CM) of the membrane is shown as loading control.
(E) Relative expression of ExEn markers during time series of cXEN conv
represents the range of three independent experiments. For each gene
Ago2 over the time of differentiation (two factors) was assessed u
p < 0.0001.
(F) ChIP-qPCR experiments on Gata6, Gata4, Sox17, and Foxa2 promo
Ago2_KO (red/light red) cells. Antibodies against SUZ12, RING1B, H
compared with a repressed (Cdx2) and an active (Smad3) promoter.
correspond to the SD of three independent experiments.
See also Figure S4.
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cXEN conversion by chromatin immunoprecipitation
(ChIP)-qPCR (Figures 4F and S4C). For both genotypes,
we observed a reduced enrichment for SUZ12 and RING1B,
suggesting a global de-repression of all ExEn promoters
during differentiation (Rugg-Gunn et al., 2010). Strikingly,
while the removal of H3K27me3 repressive marks and the
deposition ofH3K27ac activemarks on theGata6 promoter
were similar in both WT and Ago2_KO cells after conver-
sion (Figures 4F and S4C), we observed a reduction of
H3K27ac activation marks and an increase in H3K27me3
repressionmarks on theGata4, Sox17, and Foxa2 promoters
in Ago2_KO compared with WT cXENs (Figures 4F and
S4C). These observations suggest a post-transcriptional
regulation of Gata6 expression that leads to an impaired
transcriptional induction of the secondary ExEn genes dur-
ing conversion. Taken together, our data indicate that
Ago2_KO cells fail to transcriptionally activate the proper
cXEN gene expression program downstream of Gata6.
They incorrectly engage in a different cell fate where
Gata6 post-transcriptional regulation might be mediated
by multiple miRNAs (Figure S4D), suggesting a complex
cell-type-dependent combinatorial regulation.
Ago2Mutant mESCs Fail to Establish the Proper ExEn
Gene Expression Program
To further explore the differentiation defect of Ago2_KO
mESCs, we compared the expression profiles of miRNAs
and mRNAs in both WT and Ago2_KO cXEN cells after
5 days of conversion (Tables S3 and S4). Four hundred sev-
enty-six miRNAs were significantly misregulated between
Ago2_KO andWTcXENs (Figures 5A and S5A). In addition,resentative pictures of WT, Ago2_KO1, Ago2_KO2, Ago1_KO1, and
e indicated by white dashed lines. Scale bars, 50 mm.
2_KO mESCs before (ESC) and after conversion (cXEN), measured by
. The significance was assessed using a two-way ANOVA followed by
and Ago2_KO mutants compared with the WT condition after cXEN
55, ns), WT versus Ago1_KO1 (p = 0.1270, ns), WT versus Ago2_KO1
s before (ESC) and after (cXEN) conversion of WT, Ago1_KO1, and
l for the two membranes used for blotting.
oints during cXEN conversion of WT and Ago2_KO1 cells. Coomassie
ersion of Ago2_KO and WT cells, measured by RT-qPCR. The error bar
the statistical significance of the variation caused by the absence of
sing a two-way ANOVA. The p values obtained for each gene are
ters before and after cXEN conversion of WT (blue/light blue) and
3K27me3, and H3K27ac were used. The enrichment was calculated
An intergenic region was used as negative control. The error bars
Figure 5. The Transcriptome of Aberrantly Converted Ago2_KO mESCs Is Distinct from that of WT cXEN
(A) Volcano plot of differentially expressed miRNAs in Ago2_KO compared with WT cXENs. Data are represented as the mean expression of
two independent biological replicates. Significantly (2-fold change and adjusted p value < 0.01) up- and downregulated genes are
highlighted in red and blue, respectively.
(B–D) Volcano plot representing the differentially expressed genes in Ago2_KO cells compared with WT cells after cXEN conversion (B).
Data are represented as the mean expression of two independent biological replicates. Significantly (2-fold change and adjusted
p value <0.01) up- and downregulated genes are highlighted in red and blue, respectively. Heatmaps depicting the expression of (C) ExEn
and pluripotency markers and (D) fibroblast-related genes in Ago2_KO compared with WT mESCs after cXEN conversion. Two replicates are
represented before (ESC) and after differentiation (cXEN). The expression levels are represented as RPKM values (reads per kilobase of
transcript per million reads mapped).
(E) Bar graph representing the proportion of genes significantly misregulated in Ago2_KO compared with WT cells after 5 days of cXEN
conversion. The represented genes are related to mESC-relevant signaling pathways. The gene list was extracted from the KEGG database
(Hedgehog, WNT, TGF-beta, RAS, PI3K-AKT, JAK-STAT, MAPK, and pluripotency).
See also Figure S5.20% of the transcripts were misregulated: 2,514 genes were
significantly up- and 2,821 downregulated in Ago2_KO
compared with WT cXENs (Figure 5B). In accordance
with our previous results (Figure 4C), pluripotencymarkers
were strongly downregulated in both WT and Ago2_KO
cXENs, while ExEn markers were highly induced only in
WT cXENs (Figure 5C). Although both mesodermal andtrophectodermal markers were not induced in Ago2_KO
cXENs, we noted an induction of mesenchymal markers,
ectodermal, and fibroblast-related markers (Figures 5D
and S5B). This highly divergent gene expression profile is
also translated at the level of several signaling pathways
such as WNT, TGF-beta, MAPK, or HEDGEHOG pathways
(Figures 5E and S5C and Table S5), critical for regulationStem Cell Reports j Vol. 10 j 461–476 j February 13, 2018 469
of the cell-fate choice during early development (Frum and
Ralston, 2015). Collectively our data indicate thatAgo2_KO
mESCs donot adopt an ExEn identity and differentiate into
an undefined fibroblast-like cell type (Figures 4A and 5D).
Ago2_KO cXEN Differentiation Failure Is Cell
Autonomous
In vivo, the establishment of ExEn is driven by FGF4, which
is secreted by EPI-biased cells (Kang et al., 2012). Addition
of FGF4 to the conversion medium of Ago2_KO mESCs
did not rescue GATA6 protein level, nor the expression of
ExEn markers (Figures 6C and S6B), neither the formation
of XEN colonies (Figure S6C). Similarly, co-culture of
Ago2_KO mESCs with GFP-labeled WT mESCs did not
rescue their differentiation defects as shown by the absence
of cXEN colony formation (Figure 6A) or expression of the
endoderm protein FOXA2 for Ago2-deficient GFP-negative
cells (Figures 6B and S6A). These data demonstrate that
the differentiation defects of Ago2_KO mESCs are cell
autonomous.
FGF/ERK Pathway Correctly Regulates NANOG
Expression in Ago2_KO mESCs
Similar to WT cXEN, Ago2_KO cells expressed the Fgfr2
receptor and downregulated the expression of Fgf4 and
Nanog mRNAs after cXEN conversion (Figure S6D), indi-
cating that the cells normally initiate their differentiation
program. Therefore, we reasoned that the defect could be
related to the FGF/ERK signaling cascade. Consequently,
we verified the functionality of this pathway by treating
WT and Ago2_KO mESCs with two FGF receptor inhibi-
tors (AZD4547; PD173074) and one MEK inhibitor
(PD0325901) (Figure S6E). Phosphorylation of ERK was
strongly reduced in the presence of the inhibitors and
correlated with an upregulation of the NANOG protein in
both WT and Ago2_KO mESCs. Conversely, the addition
of FGF4 slightly reduced NANOG levels (Figure S6E).
Notably, we observed a different response to the FGF/ERK
inhibitors in the Ago2_KO compared with WT cells during
the conversion to cXEN, as NANOG was downregulated
even though the FGF/ERK signaling pathway was inhibited
(Figure S6F). Taken together these experiments demon-
strate that although the FGF/ERK pathway correctly regu-
lates NANOG expression in Ago2_KOmESCs, its inhibition
fails tomaintain pluripotency under differentiation culture
conditions as it does for WT mESCs.
Ago2_KO cXEN Differentiation Failure Is Bypassed by
GATA6 Overexpression
It has been shown that GATA6 overexpression alone is suf-
ficient to reprogram mESCs into XEN cells (Shimosato
et al., 2007). Therefore, we generated mESC WT and
Ago2_KO clones expressing GATA6 in an inducible470 Stem Cell Reports j Vol. 10 j 461–476 j February 13, 2018manner. After 3 days of induction, we observed the forma-
tion of XEN-like colonies and high expression of ExEn
markers in bothWT-GATA6 andAgo2_KO-GATA6 cells (Fig-
ures 6D and S6G). Therefore, GATA6 expression is suffi-
cient to induce XEN conversion in Ago2_KO mESCs,
bypassing the misregulation observed in the context of
XEN conversion. Taken together our data show that the
XEN conversion impairment of Ago2-deficient mESCs is
cell autonomous and can be rescued by exogenous
GATA6 expression.
The AGO2 Small-RNA Binding Capacity Is Required
during XEN Conversion
Finally, we performed rescue experiments by ectopically
expressing inducible hemagglutinin (HA)-tagged WT
(HA-AGO2), catalytic mutant D699A (CATmut) (O’Carroll
et al., 2007), and small-RNA-binding mutant Y311A/
Y312A (RNAmut) (Gao et al., 2014) Ago2 cDNA in
Ago2_KO1 mESCs (Figure 7A, top). After 5 days of induc-
tion, we observed a strong restoration of AGO2 protein
levels with the CATmut Ago2 transgene and a weaker but
comparable restoration with both the HA-tagged WT
Ago2 and the RNAmut Ago2 transgenes (Figure 7A). During
cXEN conversion, induction of the HA-AGO2 and CATmut
effectively rescued the impaired expression of ExEn
markers (Figure 7B). Moreover, the expression level of
groups 1 and 2 miRNAs, as well as the formation of cXEN
colonies, was restored, despite the lower level of AGO2
protein in HA-AGO2 compared with WT mESCs (Figures
7A, 7C, and 7D). In contrast, the RNAmut transgene
expression did not induce any significant change in ExEn
markers nor miRNA stabilization and the cells presented a
fibroblast-like morphology similar to that of the Ago2_KO
cells after conversion (Figures 7B–7D).
To assess if AGO1 might rescue Ago2 phenotypes, we
overexpressed AGO1 in Ago2_KO mESCs (Figures 7E and
S7A). No significant induction of ExEn markers and no
formation of XEN-like colonies were observed in
Ago2_KO-AGO1 cells after cXEN differentiation (Figures
7F and 7G). Nevertheless, we observed a global restora-
tion of the expression of both groups of miRNAs before
cXEN conversion (Figures S7B–S7D and Table S6). The
functionality of these restored miRNAs was also validated
by measuring the level of potential miRNA targets, upre-
gulated in Ago2_KO cells (Figures S1F and S7E). Taken
together, our results show that AGO2 but not AGO1 is
required for the correct induction of the ExEn markers
and the formation of cXEN colonies. We demonstrated
that AGO2 small-RNA binding capacity but not its cata-
lytic activity is essential for this differentiation process.
Moreover, AGO1 overexpression and miRNA restoration
is not sufficient to rescue Ago2_KO XEN conversion
defect.
Figure 6. cXEN Conversion Defect of Ago2_KO mESCs Is Cell Autonomous
(A) Schematic representation of the cXEN differentiation of WT and Ago2_KO cells co-cultured in a 1:1 ratio. The WT cells are GFP positive
and Ago2_KO cells are GFP negative. Representative pictures of the Ago2_KO, WT-GFP, and WT-GFP/Ago2_KO cXEN cell conversion are
shown. cXEN colonies are indicated by white dashed lines. Scale bar, 50 mm.
(B) Immunofluorescence of WT-GFP/Ago2_KO co-cultured cells after cXEN conversion. Representative picture of GFP and FOXA2 co-stained
sample is shown. The XENs that appear in the co-cultures are GFP positive. Nuclei are stained with DAPI. Ago2_KO cXEN converted cells are
shown as negative control. Scale bars, 50 mm.
(C) WT and Ago2_KO mESCs were converted to cXEN in the presence of 500 ng/mL FGF4 growth factor + 1 mg/mL heparin. Schematic
representation of the experiment is presented. Levels of AGO2, NANOG, and GATA6 in the different conditions after conversion are shown.
TUBULIN levels are shown as loading control. Undifferentiated cells (ESC) are used as controls.
(D) RT-qPCR quantification of ExEn markers (Gata6, Gata4, and Dab2) in WT-GATA6 and Ago2_KO-GATA6 mESCs, expressing exogenous
inducible GATA6, cultured in LIF/serum conditions for 3 days with or without the addition of doxycycline. The error bar represents the SD of
three replicate experiments.
See also Figure S6.DISCUSSION
In this study, we used mESCs and their differentiation
derivatives as a model system to investigate the underlying
causes of the post-implantation lethality of the Ago2mutant mouse embryos. By generating Ago1- and Ago2-
deficient mutant mESCs in the same genetic background,
we demonstrated that the deletion of either one of these
two genes had no significant effect on mESCs, cell cycle,
and self-renewal. Deletion of Ago2 compromised miRNAStem Cell Reports j Vol. 10 j 461–476 j February 13, 2018 471
Figure 7. XEN Conversion of mESCs Requires the Small-RNA Binding Capacity of AGO2
(A) Schematic representation of the inducible constructs used for the ectopic expression of HA-tagged AGO2, catalytic AGO2 mutant
(CATmut), and small-RNA-binding deficient PAZ domain AGO2 mutant (RNAmut) in Ago2_KO1 mESCs. Expression of the AGO2 constructs
after 5 days of induction with doxycycline (dox) is shown. TUBULIN is used as loading control.
(B) cXEN conversion of Ago2_KO complemented mutants with or without doxycycline. The relative expression of ExEn markers was
measured by RT-qPCR before (ESC) and after conversion (cXEN). The error bars represent the SD of three independent experiments.
(legend continued on next page)
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levels, with aweak impact on the transcriptome, indicating
its preponderant role in themiRNA pathway inmESCs and
potential compensatory function of the AGO1 protein, in
line with previous observations (Su et al., 2009). Indeed,
the upregulated AGO1 stabilizes the steady-state miRNA
level in Ago2_KO mESCs. This observation is also in accor-
dance with the previously described correlation between
AGO abundance and miRNA availability (Martinez and
Gregory, 2013; O’Carroll et al., 2007; Wang et al., 2012a;
Winter and Diederichs, 2014). Notably, miRNAs moder-
ately (group 1) or strongly affected (group 2) by Ago2
deletionwere broadly rescued byAGO1 ectopic overexpres-
sion, demonstrating a functional overlap of the two AGO
proteins in miRNA loading and stabilization in mESCs.
The miRNA levels have been shown to be important for
embryonic development (Greve et al., 2013). Indeed, Dicer
mutant embryos deprived of miRNAs die after implanta-
tion at 6.5 dpp (Bernstein et al., 2003) andDicer_KOmESCs
can be maintained in vitro but cannot exit pluripotency
(Bodak et al., 2017). The in vitro differentiation of Ago2_KO
mESCs revealed that even with reduced miRNA levels, the
cells effectively differentiate toward ectodermal, meso-
dermal, and DE lineages. The successful generation of
chimeric mice using both Ago2_KO mESC clones demon-
strated that Ago2 is dispensable for the post-implantation
differentiation processes of the embryo. Using a cXEN
conversion protocol, we proved that AGO2 is required for
ExEn differentiation. Indeed, our study revealed a severe
in vitro conversion defect of Ago2_KO mESCs toward XEN
cells. The requirement of Ago2 for the ExEn cell-fate choice
is relevant in vivo, as it is expressed from the oocyte to the
blastocyst stage (Lykke-Andersen et al., 2008; Park et al.,
2015; Wu et al., 2016) and has been shown to be present
both in embryonic and in extra-embryonic tissues
(Cheloufi et al., 2010) at embryonic day E9.5. In previous
in vivo studies, Ago2 mutant mice were generated using
insertionalmutations after exon 12, after exons 3–6 (Alisch
et al., 2007; Liu, 2004), or after exon 1 (Morita et al., 2007).
The three studies observed an early embryonic lethality
phenotype and described a developmental arrest ranging(C) Representative pictures of the WT, Ago2_KO, and the complemente
conversion with (+dox) or without (dox) induction with doxycycli
50 mm.
(D) Relative expression of miRNAs of group 1 and group 2 in the comp
by RT-qPCR. The error bars correspond to the SD of three independent
(E) Western blot showing the inducible overexpression of AGO1 in st
were induced 5 days with doxycycline. TUBULIN is used as loading co
(F) cXEN conversion of Ago2_KO-AGO1-A cells with or without doxy
RT-qPCR before (ESC) and after conversion (cXEN). The error bars rep
(G) Representative pictures of the Ago2_KO cells overexpressing AG
conversion with (+dox) or without (dox) induction with doxycyclin
See also Figure S7.from implantation to mid-gestation. Although placenta
defects have been shown to contribute to the embryonic
lethality of Ago2-deficient embryos (Cheloufi et al., 2010),
the cell-autonomous ExEn differentiation defects that we
observed in vitro may also contribute to their in vivo devel-
opmental defects. Further, in vivo studies are required to
clarify the essential role of AGO2 in PrE formation and
differentiation during early development.
We demonstrated that the cXEN conversion of mESCs
requires AGO2 small-RNA binding capacity but not its
catalytic activity, suggesting that AGO2 loaded with a
small-RNA molecule may be functionally required for this
process or for the stabilization of the AGO2 protein itself.
Interestingly, our experimental data indicate that the
global level of miRNAs is not critical for ExEn differentia-
tion, as its restoration by AGO1 ectopic overexpression
does not rescue the Ago2_KO conversion defect. A previous
study analyzed the miRNA content of cells derived from
extra-embryonic tissues and highlighted their importance
using Dicer_KO mutants (Spruce et al., 2010), in which
AGO2 is per se downregulated due to the lack of miRNAs
(Smibert et al., 2013), making it impossible to dissociate
both phenotypes. Our findings point toward the presence
of either some AGO2-specific small RNAs or non-canonical
AGO2-specific functions during the conversion process.
Furthermore, AGO2 subcellular localization may also be
altered when the protein has impaired small-RNA loading
(Nishi et al., 2015; Schraivogel et al., 2015) and in turn be
responsible for the differentiation defect.
The considerable variation of gene expression profiles
and morphology between Ago2_KO and WT cXENs indi-
cates that Ago2_KO cells differentiate into a fibroblast-
like cell fate expressing mesenchymal markers instead
of epithelial markers, normally expressed by XEN cells
(Brown et al., 2010). This impaired differentiation of
Ago2_KO cells into a different cell lineage is also illustrated
by their inconsistent response to the FGF/ERK pathway
inhibitors on NANOG and GATA6 expression (Figures
S6E and S6F). Although they exit pluripotency during
conversion, Ago2_KO cells fail to properly express GATA6d mutant (HA-AGO2, CATmut, and RNAmut) cells after 5 days of cXEN
ne. cXEN colonies are indicated by white dashed lines. Scale bars,
lemented mutants before and after 5 days of doxycycline, measured
experiments. The dashed line represents miRNA levels in WT cells.
ably transfected Ago2_KO cells (clone Ago2_KO-AGO1-A). The cells
ntrol.
cycline. The relative expression of ExEn markers was measured by
resent the SD of three independent experiments.
O1 (Ago2_KO-AGO1-A and Ago2_KO-AGO1-B) after 5 days of cXEN
e. Scale bars, 50 mm.
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protein levels and consequently to activate the ExEn gene
expression program downstream of GATA6. Importantly,
we were able to bypass this defective regulation by ectopi-
cally expressing Gata6 cDNA deprived of its 30 UTR in
Ago2_KO cells. Ago2_KO fibroblast-like cells have distinc-
tive mRNA and miRNA expression profiles compared
with WT XEN cells. Some of the upregulated miRNAs are
loaded into AGO1 and can target the Gata6 30 UTR, poten-
tially explaining the downregulation of GATA6 protein.
Alternatively, GATA6 could be destabilized in Ago2_KO
cells due to the downregulation of an unknown cofactor,
which would specifically stabilize GATA6 by preventing
its degradation, like BMI1 in fully differentiated XEN cells
(Lavial et al., 2012).
Finally, the role of AGO2 in XEN differentiation might
also be relevant for the de-differentiation or reprogram-
ming of somatic cells, as it has been recently demon-
strated that an intermediary XEN-like state is essential
for chemical generation of induced pluripotent stem cells
(Zhao et al., 2015). Interestingly, our study shows that
AGO2 is specifically required for the induction of XEN
cell fate from mESCs, which underlines the importance
of a specific RNAi pathway factor in a directed differentia-
tion process.EXPERIMENTAL PROCEDURES
Chimeric Mice Generation
Blastocyst micro-injections were performed at the EPIC transgenic
facility (ETH, Zurich). For details see the Supplemental Experi-
mental Procedures. All experiments were conducted according to
Swiss law of animal protection and with the approval of the local
institutional animal care committees (licence nos. 106/2013 and
ZH123/16).
mESC Culture
The E14mESC line (129/Ola background)was used and cultured as
described previously (Bodak et al., 2017). If required, the medium
was supplemented with 1 mg/mL doxycycline, 1 mM retinoic acid,
2 mM PD0325901, 0.1 mM PD173074, 1 mM AZD4547, or 500 ng/
mL FGF4 + 1 mg/mL heparin.
CRISPR/Cas9-Mediated Gene Knockout
TheAgo2_KO andAgo1_KO cell lines were generated using a paired
CRISPR/CAS9 strategy on WT E14 mESCs as described previously
(Wettstein et al., 2016).
cXEN Conversion of mESCs
The cXEN conversion was performed as described in Niakan et al.
(2013).
mRNA and miRNA Expression Analysis
The mRNA and miRNA extraction and quantification were per-
formed as described in Cirera-Salinas et al. (2017).474 Stem Cell Reports j Vol. 10 j 461–476 j February 13, 2018Cross-Linked Immunoprecipitation of AGO1/AGO2-
Bound Small RNAs
The RNA immunoprecipitation was performed as described in
Selth et al. (2011). The pulled-down small RNAs were analyzed
by deep sequencing.ACCESSION NUMBERS
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